Immunohistochemical analysis reveals variations in proteasome tissue expression in C. elegans.

by Elisa Mikkonen, Caj Haglund, Carina I Holmberg
Published 2017-01-01

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.

by Mira Lanki, Hanna Seppänen, Harri Mustonen, Jaana Hagström, Caj Haglund
Published 2019-01-01

MMP‐7, ‐8, ‐9, E‐cadherin, and beta‐catenin expression in 34 ameloblastoma cases

by Jetta Kelppe, Hanna Thorén, Caj Haglund, Timo Sorsa, Jaana Hagström
Published 2021-02-01

Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay

by Kajsa Björkman, Harri Mustonen, Tuomas Kaprio, Caj Haglund, Camilla Böckelman
Published 2019-07-01

Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.

by Matilda Holm, Mayank Saraswat, Sakari Joenväärä, Ari Ristimäki, Caj Haglund, Risto Renkonen
Published 2018-01-01

High PROX1 expression in gastric cancer predicts better survival.

by Alli Laitinen, Camilla Böckelman, Jaana Hagström, Arto Kokkola, Pauliina Kallio, Caj Haglund
Published 2017-01-01

The prognostic significance of tall cells in papillary thyroid carcinoma: A case-control study

by Sebastian Stenman, Päivi Siironen, Harri Mustonen, Johan Lundin, Caj Haglund, Johanna Arola
Published 2018-07-01

Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival

by Matilda Holm, Mayank Saraswat, Sakari Joenväärä, Hanna Seppänen, Risto Renkonen, Caj Haglund
Published 2020-06-01

Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.

by Selja Koskensalo, Johanna Louhimo, Jaana Hagström, Mikael Lundin, Ulf-Håkan Stenman, Caj Haglund
Published 2013-01-01

Expression of ODC Antizyme Inhibitor 2 (AZIN2) in Human Secretory Cells and Tissues.

by Tiina Rasila, Alexandra Lehtonen, Kristiina Kanerva, Laura T Mäkitie, Caj Haglund, Leif C Andersson
Published 2016-01-01

REG4 independently predicts better prognosis in non-mucinous colorectal cancer.

by Tuomas Kaprio, Jaana Hagström, Harri Mustonen, Selja Koskensalo, Leif C Andersson, Caj Haglund
Published 2014-01-01

UCHL5 expression associates with improved survival in lymph-node-positive rectal cancer

by Leena Arpalahti, Jaana Hagström, Harri Mustonen, Mikael Lundin, Caj Haglund, Carina I Holmberg
Published 2017-07-01

High serum MMP-14 predicts worse survival in gastric cancer.

by Aaro Kasurinen, Taina Tervahartiala, Alli Laitinen, Arto Kokkola, Timo Sorsa, Camilla Böckelman, Caj Haglund
Published 2018-01-01

Endoscopic sphincterotomy and risk of cholangiocarcinoma: a population-based cohort study in Finland and Sweden

by Cecilia Strömberg, Camilla Böckelman, Huan Song, Weimin Ye, Eero Pukkala, Caj Haglund, Magnus Nilsson
Published 2016-09-01

Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma

by Miia Ruuskanen, Ilmo Leivo, Heikki Minn, Tero Vahlberg, Caj Haglund, Jaana Hagström, Heikki Irjala
Published 2019-06-01

Plasma protein expression differs between colorectal cancer patients depending on primary tumor location

by Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund
Published 2020-07-01

Podocalyxin as a Prognostic Marker in Gastric Cancer.

by Alli Laitinen, Camilla Böckelman, Jaana Hagström, Arto Kokkola, Christian Fermér, Olle Nilsson, Caj Haglund
Published 2015-01-01

Differences and overlap in plasma protein expression during colorectal cancer progression

by Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund
Published 2019-08-01

The expression and prognostic value of stem cell markers Bmi-1, HESC5:3, and HES77 in human papillomavirus–positive and –negative oropharyngeal squamous cell carcinoma

by Hesham Mohamed, Jaana Hagström, Lauri Jouhi, Timo Atula, Alhadi Almangush, Antti Mäkitie, Caj Haglund
Published 2019-03-01

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer

by Annika Eurola, Ari Ristimäki, Harri Mustonen, Anna-Maria Nurmi, Jaana Hagström, Caj Haglund, Hanna Seppänen
Published 2021-05-01